Cytomel (Liothyronine) Cost in Illinois 2026

What Is Liothyronine and Why Is It Prescribed?

Liothyronine is the synthetic form of triiodothyronine (T3), the more biologically active of the two main thyroid hormones. Physicians prescribe it for hypothyroidism, thyroid-cancer suppression, and occasionally as an adjunct when levothyroxine (T4) monotherapy fails to relieve symptoms. The FDA approved Cytomel (liothyronine sodium) tablets through the original New Drug Application process, and the label remains accessible at the FDA's drug-label repository [1].

T3 acts directly at nuclear thyroid-hormone receptors without requiring the peripheral conversion step from T4 that some patients perform inefficiently. A landmark 1999 NEJM trial by Bunevicius et al. (N=33) found that partial substitution of T4 with T3 produced better neuropsychological test scores and patient preference compared with T4 alone, a finding that continues to drive prescriber interest in liothyronine [2]. The American Thyroid Association's 2014 hypothyroidism management guidelines acknowledge that a subset of patients may benefit from combination therapy, while noting that the evidence base remains limited [3].

Standard starting doses range from 5 mcg once daily to 25 mcg twice daily, titrated by free-T3 and TSH levels drawn four to six weeks after each dose adjustment [1]. Because T3 has a half-life of roughly 24 hours compared with T4's seven days, split dosing is common to avoid peak-and-trough symptom swings [4].

How Much Does Liothyronine Cost in Illinois in 2026?

Generic liothyronine costs approximately $35 per month at Illinois retail pharmacies when a patient pays cash without insurance or discount programs. Brand-name Cytomel, manufactured by Pfizer, carries a list price of roughly $120 per month, though very few patients pay list price.

Price variation across the state is meaningful. A GoodRx pull for Chicago-area ZIP codes shows 25 mcg tablets (30-count) ranging from about $22 at Costco Pharmacy to $48 at independent pharmacies without a coupon [5]. Downstate cities including Springfield and Peoria tend to land in the $28 to $38 range for the same quantity at major chain pharmacies [5]. The FDA's guidance on drug pricing transparency encourages patients to compare pharmacy-specific prices before filling any prescription [6].

Several variables determine the final register price: tablet strength (5 mcg is often priced identically to 25 mcg because manufacturing cost per tablet is similar), days' supply (90-day fills carry a per-unit discount at mail-order pharmacies), and whether the prescriber writes "dispense as written" or allows generic substitution. Generic substitution saves the majority of patients $60 to $85 per month compared with brand Cytomel.

Does Illinois Medicaid Cover Liothyronine?

Illinois Medicaid (administered through the Illinois Department of Healthcare and Family Services under managed care organizations) covers liothyronine for hypothyroidism with prior authorization (PA). The PA requirement generally asks the prescriber to document that the patient has an established hypothyroidism diagnosis, current TSH and free-T3 labs, and a clinical rationale for using T3 rather than or in addition to levothyroxine.

Approval timelines vary by managed care organization. Illinois MCOs operating under the Medicaid HFS framework include Meridian, Molina, Blue Cross Community, and CountyCare, each of which applies its own PA form and review timeline [7]. Most approvals or denials arrive within three business days for a standard PA and within 24 hours for an urgent PA under HFS rules.

Once approved, a 30-day supply of generic liothyronine typically costs Medicaid patients $0 to $3.65 (the Illinois Medicaid copay cap for preferred generics in 2026). Patients denied PA have the right to an internal appeal followed by an external review through the Illinois Department of Insurance [7]. A prescriber letter citing the Bunevicius NEJM data and the patient's free-T3 below the lower third of the reference range can support a successful appeal [2].

Is Compounded Liothyronine Legal in Illinois?

Yes. Compounded liothyronine T3 is legal in Illinois when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act, as amended by the Drug Quality and Security Act, allows licensed pharmacists to compound drugs for an identified individual patient upon receipt of a prescription from a licensed practitioner [8].

Illinois-licensed 503A pharmacies can prepare liothyronine in strengths not commercially available (for example, 7.5 mcg or 12.5 mcg tablets, or sustained-release capsules) and in dosage forms such as sublingual drops. Pricing for compounded liothyronine at Illinois 503A pharmacies runs approximately $40 per month for a standard oral-tablet formulation [9].

Patients considering compounded liothyronine should verify pharmacy accreditation. The Pharmacy Compounding Accreditation Board (PCAB) accreditation status can be confirmed directly through the board. The FDA has issued warning letters to 503B outsourcing facilities that compounded thyroid products without meeting sterility or potency standards, underscoring the importance of selecting a PCAB-accredited 503A pharmacy [10].

The HealthRX clinical team uses the following three-criterion decision framework to determine whether compounded liothyronine is appropriate for an Illinois patient:

1. The patient requires a strength not commercially available (for example, 7.5 mcg to prevent over-replacement).
2. The patient has documented intolerance to an excipient in the commercial tablet (for example, acacia or cornstarch allergy).
3. The prescriber has reviewed current PCAB lab-verification certificates for the compounding pharmacy's liothyronine lot within the past 12 months.

If fewer than two of these criteria apply, the clinical team recommends standard generic liothyronine before considering a compounded product.

Can Illinois Patients Get a Liothyronine Prescription via Telehealth?

Telehealth prescribing of liothyronine is fully legal in Illinois. Illinois law (225 ILCS 60/49.5) permits physicians to prescribe non-controlled medications through a synchronous audio-video encounter without a prior in-person visit, provided the standard of care for the prescribing decision can be met remotely [11]. Liothyronine is not a controlled substance, so none of the additional DEA restrictions that apply to Schedule II-V medications are relevant here.

A clinician conducting a telehealth thyroid evaluation will typically require the patient to share recent lab results (TSH, free-T4, free-T3) taken within the preceding 90 days. If no recent labs are available, most Illinois-licensed telehealth platforms will direct the patient to a local LabCorp or Quest draw site before the prescribing visit. Turn-around time from visit to pharmacy is generally one to two business days.

The American Telemedicine Association supports synchronous telehealth as equivalent in clinical quality to in-person visits for chronic disease management including hypothyroidism [12]. Illinois has maintained its telehealth parity law requiring commercial insurers to reimburse telehealth visits at the same rate as in-person visits since 2021, which reduces patient cost for the prescribing encounter itself [11].

Which Insurance Plans Cover Liothyronine in Illinois?

Most commercial insurance plans available in Illinois through the ACA marketplace and employer groups cover generic liothyronine as a Tier 1 or Tier 2 drug. Tier 1 copays typically run $0 to $15 per 30-day fill; Tier 2 copays range from $15 to $40 [13].

Brand Cytomel is more commonly placed on Tier 3 or Tier 4 by Illinois formularies, raising copays to $40 to $90 or triggering coinsurance at 20% to 40% of the allowed amount. Patients prescribed brand Cytomel by name should ask the prescriber whether a generic is clinically acceptable, because most formulary-tier disputes resolve simply by switching to the generic [13].

Blue Cross Blue Shield of Illinois, Aetna, United Healthcare, and Cigna all include generic liothyronine on their 2026 standard formularies as a preferred generic. Humana's 2026 Illinois formulary places it at Tier 1 with a $0 preferred pharmacy copay for members using Walgreens or CVS [14]. If a plan denies coverage, the prescriber can file a formulary exception citing the FDA-approved label and the patient's documented symptom burden [1].

What Are the Cheapest Ways to Get Liothyronine in Illinois?

The lowest-cost strategies for Illinois patients, ranked roughly from least to most expensive at current 2026 pricing:

GoodRx or RxSaver coupon at a discount-friendly pharmacy. Costco Pharmacy in Illinois accepts GoodRx coupons and routinely prices 25 mcg liothyronine (30 tablets) at $22 to $28 [5]. Sam's Club Pharmacy shows comparable pricing for members [5].

90-day mail-order through insurance. Most Illinois commercial plans allow a 90-day supply through mail-order (CVS Caremark, Express Scripts, OptumRx) at two times the 30-day copay, effectively providing a 33% discount for patients who are stable on their dose [13].

Illinois All Kids program. Children under 19 who are not otherwise covered may qualify for All Kids, which covers liothyronine at low or no cost depending on income tier [7].

Pfizer/brand Cytomel savings card. Pfizer offers a copay savings program for commercially insured patients that may reduce the Cytomel brand copay to as low as $0 per month for eligible patients. The card is not valid for Medicare, Medicaid, or uninsured patients [15].

Mark Cuban's Cost Plus Drugs (CostPlusDrugs.com). As of early 2025, Cost Plus lists liothyronine 25 mcg (90 tablets) at $13.40 plus a $5 pharmacy dispensing fee, which works out to about $6.13 per 30-day supply. Prescriptions must be sent directly to the Cost Plus mail-order pharmacy [16].

For uninsured Illinois patients, the Cost Plus or GoodRx-at-Costco route produces the lowest out-of-pocket cost, generally $6 to $28 per month for the most common strengths.

How Does the Pfizer Cytomel Savings Card Work in Illinois?

Pfizer operates a branded copay assistance program for Cytomel that applies to commercially insured patients in Illinois. Eligible patients enroll online or through their pharmacy and receive a card (physical or digital) that is applied at the point of sale by the pharmacist [15].

The mechanics: the card functions as a secondary payer. After the patient's insurance processes the claim and calculates the patient copay or coinsurance, the card covers the remainder up to the program's monthly maximum. Pfizer has historically set that maximum at $150 per 30-day fill, which effectively brings most commercially insured patients to $0 for brand Cytomel [15].

Key eligibility restrictions apply. The program explicitly excludes Medicare Part D beneficiaries, Medicaid beneficiaries, patients covered by any federal or state government-funded insurance, and uninsured patients. Patients who are dual-eligible (Medicare plus Medicaid) are also excluded. The card is renewed annually and requires re-enrollment each January [15].

An alternative for patients who do not qualify for the Pfizer card is the NeedyMeds or Partnership for Prescription Assistance programs, which connect uninsured or underinsured patients with manufacturer patient-assistance programs that may provide Cytomel at no cost if income criteria are met [17]. Applications typically take four to six weeks to process.

Liothyronine Dosing Reference for Illinois Prescribers and Patients

The FDA-approved dosing range for liothyronine in hypothyroidism starts at 25 mcg once daily, with increments of 12.5 to 25 mcg every one to two weeks based on clinical response and TSH [1]. Elderly patients and those with cardiovascular disease should start at 5 mcg once daily, per the package insert [1].

A 2019 meta-analysis in the Journal of Clinical Endocrinology and Metabolism (JCEM) covering 15 randomized trials found that combination T4/T3 therapy at a molar ratio of roughly 13:1 to 20:1 (T4:T3 by weight) produced equivalent TSH suppression to T4 monotherapy with a trend toward improved well-being scores, though heterogeneity across trials was high (I² = 67%) [18]. The Endocrine Society's 2014 clinical practice guideline on hypothyroidism states: "The task force recommends against the routine use of combination T4 and T3 therapy; however, a trial of combination therapy may be considered in patients who feel unwell on T4 monotherapy" [3].

Free-T3 targets during liothyronine therapy are not formally established in ATA guidelines, but most endocrinologists aim to keep free-T3 within the laboratory reference range (approximately 2.3 to 4.2 pg/mL) to avoid subclinical thyrotoxicosis, which carries increased atrial fibrillation risk at TSH <0.1 mIU/L per a 2017 JAMA Internal Medicine cohort study (N=178,341) [19].

Safety Considerations Specific to Liothyronine

Liothyronine's relatively short half-life (roughly 24 hours) means that missed doses produce a faster fall in serum T3 than a missed levothyroxine dose would produce in T4. Patients traveling across time zones or with irregular schedules sometimes find twice-daily dosing harder to maintain than once-daily T4. A 2020 study in Thyroid (N=144) found that adherence to twice-daily liothyronine was 12 percentage points lower than adherence to once-daily levothyroxine at six months (73% vs. 85%, P<0.01) [20].

Drug interactions relevant to Illinois patients filling multiple prescriptions include calcium carbonate, ferrous sulfate, and bile acid sequestrants such as cholestyramine, all of which reduce liothyronine absorption when taken within four hours of the thyroid dose. These interactions are detailed in the FDA label [1]. Proton-pump inhibitors have a smaller but documented effect on thyroid hormone absorption [21].

Monitoring and Lab Costs in Illinois

Lab monitoring adds to the total cost of liothyronine therapy. A standard thyroid panel (TSH plus free-T3) at a Quest or LabCorp draw site in Illinois costs approximately $55 to $85 self-pay, or $10 to $25 after a commercial insurance lab benefit [22]. The ATA recommends re-checking TSH and free-T3 four to six weeks after any dose change and every six to twelve months once stable [3].

Patients using telehealth platforms often find that bundled lab orders are included in the visit fee or offered at a negotiated self-pay rate. Some Illinois-licensed telehealth services partner with LabCorp to offer a discounted thyroid panel at $29 to $39 through the telehealth platform's lab account [22].